Table 3. Prevalence of the individual components of metabolic syndrome in the study and control groups.
| Study group (n = 276) | Control group (n = 276) | OR (95%CI) | p | |
|---|---|---|---|---|
| Metabolic Syndrome (MetS) | 23.2(64) | 19.9(55) | 1.21(0.81–1.82) | 0.35 a |
| Individual components: | ||||
| Increased waist circumference (cm) | 55.1(152) | 40.6(112) | 1.79(1.28–2.52) | <0.001 a |
| Elevated blood pressure (mmHg): | ||||
| Systolic | 17(47) | 24.3(67) | 0.64(0.42–0.97) | 0.05 a |
| Diastolic | 23.2(64) | 26.8(74) | 0.82(0.56–1.21) | 0.38 a |
| Elevated fasting plasma glucose (mmol/) | 17.4(48) | 13.8(38) | 1.32(0.83–2.09) | 0.24 a |
| Elevated serum triglycerides (mmol/l) | 14.5(40) | 12.3(34) | 1.21(0.74–1.97) | 0.45 a |
| Low HDL –cholesterol (mmol/l) | 52.5(145) | 39.9(110) | 1.67(1.19–2.34) | 0.003a |
| Number of MetS criteria met: | 0.06 b | |||
| 0 | 19.6(54) | 30.8(85) | ||
| 1 | 27.5(76) | 26.8(74) | ||
| 2 | 29.7(82) | 22.5(62) | ||
| 3 | 15.9(44) | 13.8(38) | ||
| 4 | 4.4(12) | 4.0(11) | ||
| 5 | 2.9(8) | 2.2(6) |
Data are % (n). HDL: high density lipoprotein.
a z test.
b Fisher’s exact test.